Open Access

Indigo plant leaf extract inhibits the binding of SARS‑CoV‑2 spike protein to angiotensin‑converting enzyme 2

  • Authors:
    • Man Hagiyama
    • Fuka Takeuchi
    • Aki Sugano
    • Azusa Yoneshige
    • Takao Inoue
    • Akihiro Wada
    • Hiroshi Kajiyama
    • Yutaka Takaoka
    • Kenroh Sasaki
    • Akihiko Ito
  • View Affiliations

  • Published online on: February 10, 2022     https://doi.org/10.3892/etm.2022.11200
  • Article Number: 274
  • Copyright: © Hagiyama et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) uses its S1 spike protein to bind to angiotensin‑converting enzyme 2 (ACE2) on human cells in the first step of cell entry. Tryptanthrin, extracted from leaves of the indigo plant, Polygonum tinctorium, using d‑limonene (17.3 µg/ml), is considered to inhibit ACE2‑mediated cell entry of another type of coronavirus, HCoV‑NL63. The current study examined whether this extract could inhibit the binding of the SARS‑CoV‑2 spike protein to ACE2. Binding was quantified as cell‑bound fluorescence intensity in live cell cultures in which canine kidney MDCK cells overexpressing ACE2 were incubated with fluorescein‑labeled S1 spike protein. When indigo extract, together with S1 protein, was added at 8,650x and 17,300x dilutions, fluorescence intensity decreased in a dose‑ and S1 extract‑dependent manner, without affecting cell viability. When 4.0‑nM tryptanthrin was added instead of the indigo extract, fluorescence intensity also decreased, but to a lesser degree than with indigo extract. Docking simulation analyses revealed that tryptanthrin readily bound to the receptor‑binding domain of the S1 protein, and identified 2‑ and 7‑amino acid sequences as the preferred binding sites. The indigo extract appeared to inhibit S1‑ACE2 binding at high dilutions, and evidently contained other inhibitory elements as well as tryptanthrin. This extract may be useful for the prevention or treatment of SARS‑CoV‑2 infection.
View Figures
View References

Related Articles

Journal Cover

April-2022
Volume 23 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hagiyama M, Takeuchi F, Sugano A, Yoneshige A, Inoue T, Wada A, Kajiyama H, Takaoka Y, Sasaki K, Ito A, Ito A, et al: Indigo plant leaf extract inhibits the binding of SARS‑CoV‑2 spike protein to angiotensin‑converting enzyme 2. Exp Ther Med 23: 274, 2022
APA
Hagiyama, M., Takeuchi, F., Sugano, A., Yoneshige, A., Inoue, T., Wada, A. ... Ito, A. (2022). Indigo plant leaf extract inhibits the binding of SARS‑CoV‑2 spike protein to angiotensin‑converting enzyme 2. Experimental and Therapeutic Medicine, 23, 274. https://doi.org/10.3892/etm.2022.11200
MLA
Hagiyama, M., Takeuchi, F., Sugano, A., Yoneshige, A., Inoue, T., Wada, A., Kajiyama, H., Takaoka, Y., Sasaki, K., Ito, A."Indigo plant leaf extract inhibits the binding of SARS‑CoV‑2 spike protein to angiotensin‑converting enzyme 2". Experimental and Therapeutic Medicine 23.4 (2022): 274.
Chicago
Hagiyama, M., Takeuchi, F., Sugano, A., Yoneshige, A., Inoue, T., Wada, A., Kajiyama, H., Takaoka, Y., Sasaki, K., Ito, A."Indigo plant leaf extract inhibits the binding of SARS‑CoV‑2 spike protein to angiotensin‑converting enzyme 2". Experimental and Therapeutic Medicine 23, no. 4 (2022): 274. https://doi.org/10.3892/etm.2022.11200